Provided by Tiger Trade Technology Pte. Ltd.

Aspire Biopharma Holdings Inc.

8.27
+0.46005.89%
Post-market: 8.270.00000.00%16:10 EDT
Volume:28.86K
Turnover:241.77K
Market Cap:11.60M
PE:-0.97
High:8.80
Open:7.60
Low:7.60
Close:7.81
52wk High:714.00
52wk Low:3.31
Shares:1.40M
Float Shares:1.11M
Volume Ratio:0.97
T/O Rate:2.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.5310
EPS(LYR):-491.2689
ROE:-1032.14%
ROA:60.58%
PB:0.99
PE(LYR):-0.02

Loading ...

Sep 26, 2025

Major Issues Report

Form 8-K - Current report
Sep 26, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Sep 18, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Aug 22, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 10, 2025

Major Issues Report

Form 8-K - Current report
May 28, 2025

Correspondence

Form CORRESP - Correspondence
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Apr 19, 2025

Correspondence

Form CORRESP - Correspondence
Apr 18, 2025

Major Issues Report

Form 8-K - Current report
Apr 09, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 07, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2025

Major Issues Report

Form 8-K - Current report
Feb 20, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities